These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 15287055)

  • 1. Disappearance of enlarged nuchal translucency before 14 weeks' gestation: relationship with chromosomal abnormalities and pregnancy outcome.
    Müller MA; Pajkrt E; Bleker OP; Bonsel GJ; Bilardo CM
    Ultrasound Obstet Gynecol; 2004 Aug; 24(2):169-74. PubMed ID: 15287055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
    Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
    Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of fetuses with enlarged nuchal translucency and normal karyotype.
    Bilardo CM; Pajkrt E; de Graaf I; Mol BW; Bleker OP
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):401-6. PubMed ID: 9674085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pregnancy outcome in fetuses with increased nuchal translucency thickness at 10-14 weeks of pregnancy].
    Maymon R; Dreazen E; Tovbin Y; Weinraub Z; Herman A
    Harefuah; 1999 Jun; 136(11):851-5, 916, 915. PubMed ID: 10955127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
    Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
    Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductus venosus blood flow assessment at 11 to 14 weeks of gestation and fetal outcome.
    Toyama JM; Brizot ML; Liao AW; Lopes LM; Nomura RM; Saldanha FA; Zugaib M
    Ultrasound Obstet Gynecol; 2004 Apr; 23(4):341-5. PubMed ID: 15065182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional cardiac abnormalities identified prior to 16 weeks' gestation in fetuses with increased nuchal translucency.
    Lopes LM; Brizot ML; Lopes MA; Ayello VD; Schultz R; Zugaib M
    Ultrasound Obstet Gynecol; 2003 Nov; 22(5):470-8. PubMed ID: 14618659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jugular vein and carotid artery blood flow in fetuses with increased nuchal translucency at 10-14 weeks' gestation.
    Martínez JM; Echevarría M; Gómez O; Del Río M; Borrell A; Puerto B; Fortuny A
    Ultrasound Obstet Gynecol; 2003 Nov; 22(5):464-9. PubMed ID: 14618658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
    Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
    Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal outcome in nuchal translucency with emphasis on normal fetal karyotype.
    Cha'ban FK; Van Splunder P; Los FJ; Wladimiroff JW
    Prenat Diagn; 1996 Jun; 16(6):537-41. PubMed ID: 8809895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrasound screening and diagnosis of fetal structural abnormalities between 11-14 gestational weeks].
    Markov D; Chernev T; Dimitrova V; Mazneĭkova V; Leroy Y; Jacquemyn Y; Ramaekers P; Van Bulck B; Loquet P
    Akush Ginekol (Sofiia); 2004; 43(3):3-10. PubMed ID: 15341249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
    Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
    BJOG; 2003 Jun; 110(6):584-8. PubMed ID: 12798476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome and prognosis in fetuses with increased first-trimester nuchal translucency.
    Mangione R; Guyon F; Taine L; Wen ZQ; Roux D; Vergnaud A; Maugey-Laulom B; Horovitz J; Saura R
    Fetal Diagn Ther; 2001; 16(6):360-3. PubMed ID: 11694739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses.
    Michailidis GD; Economides DL
    Ultrasound Obstet Gynecol; 2001 Feb; 17(2):102-5. PubMed ID: 11251915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester nuchal translucency measurement and echocardiography at 16 to 18 weeks of gestation in prenatal detection for trisomy 18.
    Cheng PJ; Liu CM; Chueh HY; Lin CM; Soong YK
    Prenat Diagn; 2003 Mar; 23(3):248-51. PubMed ID: 12627429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First trimester umbilical artery pulsatility index in fetuses presenting enlarged nuchal translucency.
    Zoppi MA; Ibba RM; Putzolu M; Floris M; Monni G
    Prenat Diagn; 2000 Sep; 20(9):701-4. PubMed ID: 11015696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16,260 fetuses derived from an unselected pregnant population.
    Westin M; Saltvedt S; Almström H; Grunewald C; Valentin L
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):150-8. PubMed ID: 17211897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fetal abnormalities and prognosis associated with increased nuchal translucency and abnormal karyotype].
    Saldanha FA; Brizot Mde L; Lopes LM; Liao AW; Zugaib M
    Rev Assoc Med Bras (1992); 2009; 55(1):54-9. PubMed ID: 19360279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megacystis at 10-14 weeks of gestation: chromosomal defects and outcome according to bladder length.
    Liao AW; Sebire NJ; Geerts L; Cicero S; Nicolaides KH
    Ultrasound Obstet Gynecol; 2003 Apr; 21(4):338-41. PubMed ID: 12704740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.